Global Cholesterol Testing Market is expected to reach USD 10,290.57 million by 2025 from USD 5,727.60 million in 2018, at a CAGR of 7.7% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Request for Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-cholesterol-testing-market
GROWING NUMBER OF CARDIOVASCULAR DISEASES AND OBESITY
The risen cholesterol levels are one of the major factors in the rise of heart diseases. Some of the statistics for cardiovascular disease and obesity is mentioned below:
•According to Centers for Disease Control and Prevention (CDC), approximately 610,000 people die due to heart disease in the U.S. per year.
•According to European Heart Network, every year cardiovascular disease leads to 3.9 million deaths in Europe and around 1.8 million deaths in the European Union.
•According to American Heart Association, in the U.S. more than one-third (approximately 35.0%) of adults are obese (over 78 million adults).
•According to Heart Foundation, in 2011, the prevalence of high cholesterol increases in the age of 55 to 64 years, and half of the population among them have high total cholesterol level.
HIGHER GROWING NUMBER OF GERIATRIC POPULATION
•According to an article published in NCBI, elderly population and Western lifestyles have become major factors in the developing countries for producing higher levels of cholesterol, which caused an increase in the occurrence of cardiovascular disease and death.
•As per Population Reference Bureau, in 2016 the number of Americans between the age bracket of 65 and above was 46 million and this number will be 98 million by 2060. The group share of 65 and older age will rise to 24% from 15%.
•According to World Population Ageing, the number of older people generally having age of 60 years or more is expected to increase from 841 million in 2013 to more than 2 billion in 2050.
To Request For TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-cholesterol-testing-market
Segmentation: Global Cholesterol Testing Market
Global Cholesterol Testing Market By Product Type (Test Kits, Testing Strips), By Test (Lipid Panel Test/Complete Lipid Profile {Total Cholesterol Test, HDL Cholesterol Test, LDL Cholesterol Test, Triglycerides/VLDL Cholesterol Test}, By Test Type (Non-Invasive, Invasive), By Prescription Mode (Over The Counter, Prescription Based), By End-Users (Clinics, Hospitals, Ambulatory Centers, Homecare, Diagnostic Centers), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)
Drivers: Global Cholesterol Testing Market
The major factors driving the growth of this market are technological advancements in cholesterol testing, growing number of cardiovascular diseases and obesity, higher growing number of geriatric population, rising awareness and acceptance of preventive healthcare and increasing cholesterol home/self-testing market are boosting the growth of the global cholesterol testing market.
TECHNOLOGICAL ADVANCEMENTS IN CHOLESTEROL TESTING
•In July 2016, Alere entered into a partnership with healthcare technology company BioIQ for providing interface between BioIQ’s software platform, SoftSuite Dx and the Alere Cholestech LDX System for the point of care lipid profile and glucose results for employee biometric screening events.
•In November 2014, Roche Diagnostics Ltd. received FDA Clearance for Strep A Test on cobasLiat System, the first molecular point of care test.
The new technologies are emerging in the market that is helpful for the non-invasive techniques of cholesterol testing. This will enhance the growth of the cholesterol testing market.
Inquiry Before Buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cholesterol-testing-market
Some of the Major Players Operating in this Market are:
•Abbott Laboratories,
•Accutech,
•LLC,
•Beckman Coulter Inc.,
•Bio-Rad Laboratories Inc.,
•Prima Lab SA,
•Quest Diagnostics Inc.,
•Home Access Health Corporation,
•Hoffmann-La Roche AG,
•Siemens AG, and
•Sigma-Aldrich Corp. among others.
Key Points: Global Cholesterol Testing Market
•In 2017, the global cholesterol testing market is dominated by F. Hoffmann-La Roche Ltd, followed by Siemens AG and Abbott
•The test kits segment is dominating the global cholesterol-testing market.
•The cholesterol testing market is dominating in Asia-Pacific region for the period 2018 to 2025.
More information for Report @ https://databridgemarketresearch.com/news/product-launch/global-cholesterol-testing-market/
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]